The funding, led by Windham Capital Partners, will further fuel TailorMed’s mission to eliminate barriers to care for millions of patients

November 21, 2024 12:00 PM Eastern Standard Time

NEW YORK–(BUSINESS WIRE)–Today, TailorMed, a leading innovator in healthcare technology, announced a $40 million financing round combining equity and debt. This investment positions the company to advance its bold vision of transforming medication access, adherence, and affordability across the United States. Windham Capital Partners led the round, alongside Citi Impact Fund, Samsung Next, and BrightEdge, and the investment arms of some of the nation’s top health systems: Providence Ventures, OSF Healthcare, Inception Health, Ballad Ventures, UH Ventures, and UnityPoint Health Ventures. TailorMed also benefited from the continued support of its early investors: Sanara Ventures, Triventures, Accelmed, Almeda Ventures, and Bridges. The debt facility was led by Poalim-tech, part of Israel’s leading bank, Bank HaPoalim.

“This new funding will fuel our mission to break down even more barriers to care, creating a healthcare system where affordability is the standard, not the exception, and working with patients and care teams to alleviate whatever barrier that comes next.”Post this

Today, only 55% of U.S. adults can afford the care they need, leading to delayed or skipped treatments that worsen health outcomes. Over 100 million Americans are weighed down by medical debt, which contributes to 65% of all bankruptcies. TailorMed has built the nation’s largest affordability network, uniting patients, providers, pharmacies, and life science companies to solve this critical challenge. By addressing patients’ fundamental need for affordable medication, anywhere a prescription is written or dispensed, TailorMed is uniquely positioned to unlock the full spectrum of medication access. This means supporting patients at every stage of their care journeys, whether at the doctor’s office, the pharmacy counter, an infusion center, or at home. Having reached an inflection point in its network evolution, the company is building an end-to-end platform that tackles cost barriers, access barriers, and beyond.

TailorMed’s success in solving the crucial barrier of affordability, coupled with its robust network, empowers the company to broadly address challenges along the medication continuum. Building upon its trusted relationships with providers, pharmacies, and life sciences, TailorMed will create a seamless flow of data and resources, enabling all stakeholders across the network to collaborate more effectively.

“In the past six years, we’ve built incredible momentum by empowering our network of leading health systems, pharmacies, and life science companies to drive affordability on a massive scale,” said Srulik Dvorsky, CEO and Co-Founder of TailorMed. “But we’re just getting started. This new funding will fuel our mission to break down even more barriers to care, creating a healthcare system where affordability is the standard, not the exception, and working with patients and care teams to alleviate whatever barrier that comes next. We’re excited to have the backing of Windham Capital Partners and other forward-thinking investors who share our vision of transforming access to care for millions.”

“TailorMed has a history of driving transformational change to address the critical challenges in the healthcare system and our nation’s affordability crisis. We are inspired to see the company taking a bold leap forward to tackle all barriers to care,” said Adam Fine, Founder and General Partner of Windham Capital Partners. “We are proud to support TailorMed as it builds a new category in healthcare, creating meaningful improvements to patient care while also delivering real traction for healthcare organizations.”

“TailorMed’s platform ensures all patients can access essential treatment without delay or facing bankruptcy,” added David Kereiakes, Managing Partner of Windham. Mr. Kereiakes will retain his Board Director role at TailorMed, now representing Windham, and will be accompanied by Dan Galles, Partner, Providence Ventures.

About TailorMed
TailorMed is a comprehensive, end-to-end platform designed to eliminate barriers along the entire medication journey, from affordability to access and adherence. TailorMed is building a new category in healthcare, transforming how stakeholders—patients, providers, pharmacies, life sciences, and payers—work together to ensure that every patient, across all medical conditions, can receive the treatment they need without delay. TailorMed’s enterprise solution manages the full lifecycle of patient support programs, reducing the cost of care and driving better outcomes. Thanks to its partnerships with life sciences, TailorMed creates unparalleled automation through direct integration with manufacturer assistance programs. With the nation’s largest Affordability Network, deployed across more than 800 hospitals, 1,300 clinics, and 650 pharmacies, TailorMed powers organizations to create a seamless patient experience. Learn more at tailormed.co.

About Windham Capital Partners
Windham Capital Partners, headquartered in New York, is a growth equity investment firm working at the intersection of medical technology and digital health. The firm invests in transformative companies and teams improving clinical outcomes, expanding access to quality healthcare and creating more efficiencies in healthcare. With deep expertise and a far-reaching network across medical devices, digital health, and life sciences, Windham partners with visionary founders and entrepreneurs to develop and elevate the standard of healthcare. Supported by a network of industry experts, including an esteemed Advisory Board of business leaders, scientists, clinicians, and fund managers, Windham Capital is dedicated to driving innovation and fostering the growth of game changing healthtech solutions through the successes of its portfolio companies. For more information, please visit Windham Capital Partners.

Contacts

Media:
Jennifer Martin
jenm@tailormed.co

Philip Robertson
probertson@impactpartners.llc

(c)2024 Business Wire, Inc., All rights reserved.